4//SEC Filing
Insys Therapeutics, Inc. 4
Accession 0001209191-17-003809
CIK 0001516479operating
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 10:40 AM ET
Size
5.4 KB
Accession
0001209191-17-003809
Insider Transaction Report
Form 4
Vetticaden Santosh
Interim CEO and CMO
Transactions
- Award
Employee Stock Option (right to buy)
2017-01-12+30,000→ 30,000 totalExercise: $10.39Exp: 2027-01-12→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option vests in 48 equal monthly installments and will be fully vested and exercisable on January 12, 2021.
Documents
Issuer
Insys Therapeutics, Inc.
CIK 0001516479
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001516479
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 10:40 AM ET
- Size
- 5.4 KB